Apple Cider Vinegar Beneficial for Overweight, Obese Individuals
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 13, 2024 -- For overweight and obese individuals, apple cider vinegar (ACV) consumption is associated with a significant reduction in anthropometric variables, as well as improvement in blood glucose triglyceride and cholesterol levels, according to a study published online March 12 in BMJ Nutrition, Prevention & Health.
Rony Abou-Khalil, Ph.D., from the Holy Spirit University of Kaslik in Jounieh, Lebanon, and colleagues examined the effects of ACV consumption on weight and blood glucose, triglyceride, and cholesterol levels in 120 individuals of the Lebanese population with overweight and obesity. Participants were randomly assigned to an intervention group receiving 5, 10, or 15 mL of ACV or a control group receiving a placebo during a 12-week period. At weeks 0, 4, 8, and 12, measurements of anthropometric parameters, fasting blood glucose, and triglyceride and cholesterol levels were taken.
The researchers observed associations for daily consumption of the three doses of ACV for four to 12 weeks with significant reductions in anthropometric variables (weight, body mass index, waist/hip circumferences, and body fat ratio), blood glucose, and triglyceride and cholesterol levels. During the 12 weeks of ACV intake, there were no significant risk factors observed.
"These results suggest that ACV might have potential benefits in improving metabolic parameters related to obesity and metabolic disorders in obese individuals," the authors write. "The results may contribute to evidence-based recommendations for the use of ACV as a dietary intervention in the management of obesity."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Small Differences in Weight Change With First-Line Antidepressants
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among...
Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD
THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.